Clinical Trials Directory

Trials / Unknown

UnknownNCT01934049

Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty

The Effect of Dexmedetomidine on Postoperative Recovery in Elderly Patients With Femoral Neck Fracture Undergoing Hip Hemi-arthroplasty

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

Hip fractures incidence grows rapidly with the aging of the population. After indicated surgical treatment, hip fracture patients experience high rates of postoperative complications, postoperative delirium (PD), postoperative cognitive dysfunction (POCD), leading to poor postoperative recovery during hospitalization, which can cause disability, distress for both patients and their families, are associated with other medical complications and account for significant additional health care costs. We currently use dexmedetomidine in elderly patients with hip fractures undergoing hip hemi-arthroplasty in order to improve postoperative recovery and prevent and treating PD and POCD. Dexmedetomidine is a drug used for sedation in critically ill patients that provides some pain relief and controls the bodies response to stress. The sedation produced by dexmedetomidine appears more similar to natural sleep than any other drug used for anesthesia and postoperative sedation. Data suggesting that dexmedetomidine can prevent delirium following cardiac surgery and the developing understanding of the causes of PD and POCD suggest that dexmedetomidine will be particularly effective.

Conditions

Interventions

TypeNameDescription
PROCEDUREhip arthroplastyEvery patient with femoral neck fractures must undergo hip hemi-arthroplasty.
DRUGTotal Intravenous Anesthesia and Peripheral nerve blocksEvery patient receives Peripheral nerve blocks and Total Intravenous Anesthesia with propofol

Timeline

Start date
2013-09-01
Primary completion
2014-02-01
Completion
2014-06-01
First posted
2013-09-04
Last updated
2013-09-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01934049. Inclusion in this directory is not an endorsement.